{"public_id":"cl_29f54d4719279e23d67d650d2abd1bcc","status":"active","superseded_by_public_id":null,"corpus_id":206965028,"text":"Induction of IFN-λ3 by nucleotide analogues represents an additional pharmacological effect and suggests a new potential target for HBV treatment.","confidence":0.8,"paper":{"corpus_id":206965028,"title":"Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection","url":"https://sah.borca.ai/papers/206965028"},"contributors":[{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["extraction"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.8,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_77302d58044a3fc589d0e1ade64b3964","name":"nucleotide analogues","description":"Antiviral drugs adefovir and tenofovir, which in this study induce IFN-λ3 production.","types":["drug class"],"url":"https://sah.borca.ai/concepts/co_77302d58044a3fc589d0e1ade64b3964"},{"public_id":"co_7c238a4a1b01d767b935384b1d02ae64","name":"additional pharmacological effect","description":"The non-canonical effect of nucleotide analogues inducing IFN-λ3, beyond their direct antiviral activity.","types":["phenomenon","mechanism"],"url":"https://sah.borca.ai/concepts/co_7c238a4a1b01d767b935384b1d02ae64"},{"public_id":"co_ccfd2420fb7fb91e3707a9b673af4528","name":"IFN-λ3","description":"Interferon lambda 3, a cytokine with antiviral effects measured in serum and in vitro in this study.","types":["protein","biomarker"],"url":"https://sah.borca.ai/concepts/co_ccfd2420fb7fb91e3707a9b673af4528"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_29f54d4719279e23d67d650d2abd1bcc"}